WebMonoclonal Antibody for studying CTGF. Cited in 36 publications. Validated for Western Blotting, Immunofluorescence (Immunocytochemistry). Highly specific and rigorously validated in-house, CTGF (D8Z8U) Rabbit Monoclonal Antibody (CST #86641) is ready to ship. ... Antibody Dilution Buffer (1X PBS / 1% BSA / 0.3% Triton X-100): To prepare 10 … WebAug 24, 2024 · CTGF, a protein localized in the extracellular matrix, is a driver of fibrotic tissue remodeling as a consequence of an aberrant wound healing process.
FibroGen Announces First Patient Dosed in ZEPHYRUS, a Phase 3 Clinical …
WebOct 14, 2014 · Clinical trials of anti-CTGF antibodies in idiopathic pulmonary fibrosis and pancreatic cancer have been initiated. 51,52,53,54,55,56. In cardiovascular models, the role of CTGF is still highly ... WebJan 12, 2011 · San Francisco, CA - January 12, 2011. FibroGen, Inc. today announced initiation of an open-label phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fatal lung … green county high school mississippi
Pamrevlumab Trials FibroGen
WebJun 22, 2006 · FibroGen, Inc., today announced the publication of two studies demonstrating that connective tissue growth factor (CTGF) plays a causative role in pancreatic cancer … WebJul 22, 2024 · Pamrevlumab, an anti-CTGF human monoclonal antibody, is advancing towards Phase 3 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF) and pancreatic cancer, and is currently in a Phase 2 trial for Duchenne muscular dystrophy (DMD). FibroGen is also developing a biosynthetic cornea in China. WebJun 6, 2012 · The mechanism by which CTGF enables persistent fibrosis upon stimulation by TGFβ has never been elucidated, due at least in part to the very complex … green county ky board of education